Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Embark Launches Dog DNA Breed & Health Test Platform
  • USA - English


News provided by

Embark Veterinary Inc

May 30, 2016, 07:45 ET

Share this article

Share toX

Share this article

Share toX

Embark: Dog DNA Testing
Embark: Dog DNA Testing

“Embark’s mission is to provide our customers with the most comprehensive look at their dog’s genetic makeup, and to be able to make informed decisions about health, diet, exercise, and overall wellness,” said Ryan Boyko, CEO.

Post this

AUSTIN, TEXAS (PRWEB) May 30, 2016 -- Embark Veterinary Inc., in partnership with the Cornell University College of Veterinary Medicine, is launching a new comprehensive dog DNA test to improve dog health and wellness. The Embark Dog DNA Test tracks over 200,000 genetic markers, offering ancestry analysis as well as key insights into genetic disease risk and heritable traits. Until now, a conscientious dog owner who wanted to know if their dog was at risk for genetic defects had to research their dog’s breed, select their top worries, and run multiple tests. Today, Embark is putting 160+ genetic results all on a single test, enabling dog owners to understand their dog’s health, plan for their future, and provide the most personalized care possible.

“Embark’s mission is to provide our customers with the most comprehensive look at their dog’s genetic makeup, and to be able to make informed decisions about health, diet, exercise, and overall wellness,” said Ryan Boyko, CEO. Unlike products currently on the market, Embark goes beyond breed identification and explains why a dog looks, sheds, and plays the way it does. As the company uncovers new genetic disease markers, Embark will retroactively update all customers’ results where possible, giving them life-long insight and discovery.

Dogs are statistically more likely to be affected with a genetic disease than their humans. For mixed-breed dogs, Embark can determine what percent of the genome comes from each breed. Embark looks at mutations that occur in each breed to determine if a dog is at risk of developing any of these conditions. This information is provided to owners via an interactive website and as a Vet Report, designed specifically for owners to bring to their vets to help guide healthcare decisions. Knowing a dog’s genetic predisposition for disease can help owners take precautionary measures or know what to watch for to avoid costly veterinary services, including ER visits where an overnight stay can cost up to $1000.

“Hundreds of thousands of dogs are tested every year for single issues, but not on scientific-grade chips. With scientific-grade chips, no only can owners get a more complete picture of their dog’s unique genetic make-up, but we can make real scientific advances that improve our understanding of dog genetics to get to healthier and happier dogs,” said Dr. Adam Boyko, Chief Science Officer and Assistant Professor of Biomedical Sciences at the Cornell veterinary college. “It’s a huge research opportunity, and we want to facilitate and lead this effort to advance our understanding of conditions like cancer, immune disorders, cardiac disease, hip dysplasia, and aging.”

For $199 and a dog’s mouth swab of DNA, Embark provides owners an interactive interface to explore their dog’s breed information and results for over 160 genetic diseases and conditions. To purchase an Embark Dog DNA Test, please visit http://www.embarkvet.com.

About Embark:
Embark Veterinary, Inc. was founded in July 2015 and has since raised over $1.8 million in seed-round investment, including substantial investments from Slow Ventures and the Aspiration Growth Fund. Embark is headquartered in Austin, Texas and is an official research partner of the Cornell University College of Veterinary Medicine and a client company of the Kevin M. McGovern Family Center for Venture Development in the Life Sciences at Cornell University.

Ryan and Adam Boyko have spent the last decade learning everything they could about dogs - how did they first get humans to fall in love with them, how did humans and dogs change each other in the years since then, and how can we best care for our furry family members? In the course of their quest to understand the domestic dog, they have discovered many of the things that make every breed and every individual dog unique. This led to breakthrough research on the origin of the domestic dog near Central Asia over 15,000 years ago. While they enjoy working in the lab and doing field research around the globe, Adam and Ryan have always wanted to share their work and improve the lives of dogs in homes across the world. They founded Embark to bring cutting-edge science and insights directly to dog owners.

###

*MEDIA NOTE:
For media inquiries or interview requests, please contact:

Hannah Russin
4157348283
press(at)embarkvet(dot)com

Hannah Russin, Embark Veterinary Inc, http://www.embarkvet.com, +1 (415) 734-8283, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.